ASHG 2019

Recent articles

RNA, transcription

Antidote to ‘poison’ DNA may treat lethal form of epilepsy

An experimental drug silences a DNA segment and seems to prevent seizures and death in a condition related to autism.

By Nicholette Zeliadt
26 August 2020 | 3 min read

Brain ‘organoids’ point to new drug target for fragile X syndrome

New findings hint at why drugs that work in mouse models of fragile X syndrome have not been effective in people.

By Nicholette Zeliadt
18 October 2019 | 3 min read
Illustration of a DNA strand.

Massive project doubles list of genes tied to autism

The largest analysis of sequences from autistic people and their families implicates 184 genes in the condition — nearly doubling the previous estimate.

By Nicholette Zeliadt
17 October 2019 | 3 min read

Explore more from The Transmitter

Illustration of a brain and screens of computer code.

Should neuroscientists ‘vibe code’?

Researchers are developing software entirely through natural language conversations with advanced large language models. The trend is transforming how research gets done—but it also presents new challenges for evaluating the outcomes.

By Benjamin Dichter
25 August 2025 | 7 min read
Bag of umbilical cord blood.

Why hype for autism stem cell therapies continues despite dead ends

After numerous tests, there is still no evidence that these experimental treatments help, so now is not the time to expand access to them.

By Paul Knoepfler
22 August 2025 | 6 min read
Research image of cortical maps of somatosensation.

Adult human cortex does not reorganize after amputation

The results from a new longitudinal study contradict classic findings in monkeys but may not warrant a rewriting of the textbooks just yet.

By Angie Voyles Askham
21 August 2025 | 8 min listen

privacy consent banner

Privacy Preference

We use cookies to provide you with the best online experience. By clicking “Accept All,” you help us understand how our site is used and enhance its performance. You can change your choice at any time. To learn more, please visit our Privacy Policy.